This site is intended for Healthcare professionals only.

Fluoroquinolones associated with risk of Achilles tendon rupture, finds new study

Fluoroquinolones associated with risk of Achilles tendon rupture, finds new study

Administration os fluoroquinolones are associated with an increased risk of Achilles tendon rupture but to a lesser extent in bicep tendon rupture. However, in both cases, the attributable risk is low. The study appeared in the journal of the British pharmaceutical society.

Fluoroquinolones are antibiotics that are commonly used to treat a variety of illnesses such as respiratory and urinary tract infections. However, some people who take these medicines may develop disabling and potentially permanent side effects of the tendons, muscles, joints, nerves, and central nervous system. These can occur in someone all at the same time. The FDA has approved changes to the labels and medication guides of fluoroquinolones taken by mouth or by injection based on patient reports of side effects.

The investigators of Boston Collaborative Drug Surveillance Program, Lexington, MA, USA, conducted cohort and nested case‐control studies which included fluoroquinolone users in the United Kingdom Clinical Practice Research Datalink Gold,  to ascertain the relative, absolute, and attributable risk of non‐traumatic tendon rupture, at various sites, associated with use of fluoroquinolones, with and without concomitant corticosteroids.

The investigators estimated the excess risk (cohort analysis) and odds ratios (ORs) (case-control) of tendon rupture by fluoroquinolone (current, recent and past use verses unexposed) and corticosteroid (current versus unexposed) use.

The investigators identified 3957 cases of tendon rupture among 740,926 patients with a fluoroquinolone prescription. The excess risk due to current fluoroquinolone use was low: any tendon rupture 3.73  per 10,000 person‐years and Achilles tendon rupture 2.91 per 10,000 PY. The excess risk of any tendon rupture was much higher for current concomitant fluoroquinolone and corticosteroid use versus corticosteroids alone: 21.2 per 10,000 PY. In the case‐control, OR  among current fluoroquinolone users versus unexposed patients was elevated: any tendon rupture 1.60, Achilles tendon 2.71 and bicep tendon 1.53. The risk of any tendon rupture was higher among women, patients aged 60+, and concomitant corticosteroid use.

The investigators found an increase in the risk of Achilles tendon rupture in patients taking Fluoroquinolones. Fluoroquinolones also increased the risk of bicep tendon rupture but to a lesser extent. But in both cases, the attributable risk is low. Furthermore,  the researchers found that the risk is materially increased with concomitant use of corticosteroids.

Read more about this article on

Source: self

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted
  1. Thank you for this article on fluoroquinolones, or FQs. I was the closing speaker at the meeting with FDA and CDC doctors which resulted in the warning and label changes in 2016. I just want to make sure that people are aware that the adverse drug reactions (ADRs) to FQs are often quite severe and can be permanently disabling. We suffer a syndrome with head to toe devastation on a cellular level that causes a wide variety of health issues to set in either simultaneously or in rapid succession. FQ ADRs are anything but rare. In fact, they are incredibly common but they are routinely misdiagnosed. I urge everyone to look into this further. Google \”fluoroquinolone toxicity\” and \”floxed\”, the slang term for our condition. The FDA uses fluoroquinolone associated disability, or FQAD. Best wishes to all!